Dyslipidemia in Patients with Coronary Heart Disease and Cardiovascular Disease Risk Stratified Filtering

被引:0
|
作者
Ma, Chunhua [1 ,2 ]
机构
[1] Eastern Liaoning Univ, Dandong 118003, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Beijing 100053, Peoples R China
来源
PROCEEDINGS OF THE 2017 2ND INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND ARTIFICIAL INTELLIGENCE (CAAI 2017) | 2017年 / 134卷
关键词
coronary heart disease; cardiovascular disease (CVD); dyslipidemia; microns; screening;
D O I
暂无
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Dyslipidemia AS one of the most important risk factors, with a variety of CAD and other AS sex of CVD occurrence is closely related to the oxidation of lipoprotein also plays a key role in the patients. A large number of research confirmed that high. X - LDL and ox - Lp (a) level is AS strong risk factors, can be used AS a CAD diagnosis especially effective index of the differential diagnosis of ACS. Micronics AS a kind of about 19 to 24 nuclear acid's long no coding single small RNA molecules that control gene expression in the translation level for. Macrons with high tissue specificity, but due to the organization based the inconvenience, are limited in clinical application, by contrast, serum or plasma microns' high stability, specificity, and conveniently, is expected to become a new diagnosis of the related diseases.. In recent years, the study found the miRNA and cardiovascular system development, differentiation and AS CVD is closely related to the occurrence and development of all, it may be involved in regulation of the variety of the AS related path physiological process; serum or blood macrons are expected to be CAD of effective molecular markers, and. X - LDL, ox - Lp (a) the common application in clinical diagnosis, condition monitoring and prognosis judgments of CAD, and achieve early identification and diagnosis of ACS.
引用
收藏
页码:480 / 482
页数:3
相关论文
共 50 条
  • [21] CARDIOVASCULAR SCREENING TO ASSESS RISK OF CORONARY HEART DISEASE
    DOYLE, JT
    KINCH, SH
    BROWN, DF
    PUBLIC HEALTH REPORTS, 1968, 83 (08) : 659 - 667
  • [22] Telomere length as a biomarker of the risk of cardiovascular complications in patients with coronary heart disease
    Doroshchuk, N. A.
    Lankin, V. Z.
    Tikhaze, A. K.
    Kheimets, G., I
    Smirnova, M. D.
    Chazova, I. E.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (01) : 20 - 24
  • [23] Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile
    De Bacquer, Dirk
    van de Luitgaarden, Inge A. T.
    De Smedt, Delphine
    Vynckier, Pieter
    Bruthans, Jan
    Fras, Zlatko
    Jankowski, Piotr
    Dolzhenko, Marina
    Kotseva, Kornelia
    Wood, David
    De Backer, Guy
    HEART, 2021, 107 (10) : 799 - 806
  • [24] Cognitive performance in patients with coronary heart disease and cardiovascular risk factors in Chile
    Delgado-Derio, C.
    Vasquez-Vivar, C.
    Orellana-Pineda, P.
    Reccius-Meza, A.
    Donoso-Sepulveda, A.
    Behrens-Pellegrino, M. I.
    REVISTA DE NEUROLOGIA, 2008, 46 (01) : 24 - 29
  • [25] Perspectives on dyslipidemia and coronary heart disease in women
    Bittner, V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (09) : 1628 - 1635
  • [26] Efficacy and safety of atorvastatin in Romanian patients with dyslipidemia and/or coronary heart disease
    Balanescu, Serban
    Ionescu, Mariana
    Bischofberger, Gabriela
    Russ, Cristina
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 : S11 - S11
  • [27] Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
    Amirov, N. B.
    Potapova, M. V.
    Ishkineev, F. I.
    Tukhvatullina, G. V.
    Efimova, N. G.
    Mingazutdinova, L. F.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (07): : 55 - 58
  • [28] Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease
    Grandi, Norma Christine
    Breitling, Lutz Philipp
    Vossen, Carla Yvonne
    Hahmann, Harry
    Wuesten, Bernd
    Maerz, Winfried
    Rothenbacher, Dietrich
    Brenner, Hermann
    AMERICAN HEART JOURNAL, 2010, 159 (06) : 1044 - 1051
  • [29] Management of Dyslipidemia for Cardiovascular Disease Risk Reduction
    Tobert, Jonathan A.
    Newman, Connie B.
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (07) : 509 - 509
  • [30] Coronary artery disease and cardiovascular risk factors in adults with congenital heart disease
    Tomkiewicz-Pajak, Lidia
    Skubera, Maciej
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (02):